Zobrazeno 1 - 10
of 51
pro vyhledávání: '"F. Sinicrope"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
F. Sinicrope, Steven R. Alberts, Daniel J. Sargent, Monica M. Bertagnolli, Robert S. Warren, Garth D. Nelson, Thomas C. Smyrk, Richard M. Goldberg, Stephen N. Thibodeau, Michelle R. Mahoney
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 31, iss 29
Purpose The association of deficient DNA mismatch repair (dMMR) with prognosis in patients with colon cancer treated with adjuvant fluorouracil, leucovorin, and oxaliplatin (FOLFOX) chemotherapy remains unknown. Patients and Methods Resected, stage I
Autor:
Jean Francois Seitz, Daniel J. Sargent, Roberto Labianca, Aimery deGramont, Al B. Benson, Greg Yothers, Nathan R. Foster, Richard M. Goldberg, F. Sinicrope, Michael J. O'Connell
Publikováno v:
Cancer. 119:1528-1536
BACKGROUND: Although obesity is an established risk factor for developing colon cancer, its prognostic impact and relation to patient sex in colon cancer survivors remains unclear. METHODS: The authors examined the prognostic and predictive impact of
Autor:
Stephen N. Thibodeau, Richard M. Goldberg, F. Sinicrope, Harry H. Yoon, Daniel J. Sargent, Qian Shi, Steven R. Alberts
Background: It is unknown if, after controlling for clinicopathologic variables and treatment, racial disparities in colon cancer outcomes persist. Molecular marker analysis in North American patients comparing Asians with other races has not been re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::586b5035efcf8b8e23d919d6555cc282
https://europepmc.org/articles/PMC5758035/
https://europepmc.org/articles/PMC5758035/
Autor:
Emily Pavey, Steven R. Alberts, Adam M. Lee, Jeffrey L. Berenberg, Robert B. Diasio, Richard M. Goldberg, F. Sinicrope, Daniel J. Sargent, Qian Shi
Publikováno v:
JNCI: Journal of the National Cancer Institute. 106
Previous studies have suggested the potential importance of three DPYD variants (DPYD*2A, D949V, and I560S) with increased 5-FU toxicity. Their individual associations, however, in 5-FU-based combination therapies, remain controversial and require fu
Publikováno v:
Clinical Colorectal Cancer. 5:211-213
Rationale For many years, adjuvant therapy for resected stage III colon cancer consisted of 5-fluorouracil (5-FU) and leucovorin (LV) administered on one of several different schedules. More recently, oxaliplatin was introduced into the treatment of
Autor:
Greg Yothers, Daniel A. Nikcevich, F. Sinicrope, Harry H. Yoon, George P. Kim, Thomas C. Smyrk, Nathan R. Foster, Carmen J. Allegra, Daniel J. Sargent
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(4)
Purpose Although the importance of obesity in colon cancer risk and outcome is recognized, the association of body mass index (BMI) with DNA mismatch repair (MMR) status is unknown. Patients and Methods BMI (kg/m2) was determined in patients with TNM
Publikováno v:
Journal of Social Work Education. 26:266-272
Researchers have suggested that practicum planning might be improved by considering student ratings of the practicum. However, deriving decision aids from empirical studies on the field experience is problematic because validity and reliability of st
Autor:
Steven R. Alberts, F. Sinicrope
Publikováno v:
Oncology Issues. 23:20-21
Autor:
J.F. Seitz, Greg Yothers, A. de Gramont, D. G. Haller, D. J. Sargent, Jacqueline Benedetti, F. Sinicrope, Nathan R. Foster, Al B. Benson, R. Labianca, Richard M. Goldberg
Publikováno v:
Journal of Clinical Oncology. 29:e21126-e21126
e21126 Background: Obesity is an established risk factor for developing colon cancer. We determined the impact of body mass index (BMI) upon prognosis and treatment benefit using the Adjuvant Colon...